SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

GlaxoSmithKline Pharmaceuticals informs about financial results

24 May 2019 Evaluate

GlaxoSmithKline Pharmaceuticals has informed about Audited Financial Results Publication for Quarter & year ended 31st March 2019.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2328.40 -4.45 (-0.19%)
22-Jun-2026 13:08 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1860.00
Dr. Reddys Lab 1296.40
Cipla 1412.00
Zydus Lifesciences 1073.00
Lupin 2345.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: